OPEN END TURBO BEAR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HC6FJR9

Market Closed - BOERSE MUENCHEN 01:15:15 25/05/2024 am IST
1.26 EUR -5.97% Intraday chart for OPEN END TURBO BEAR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-4.55%
1 month-9.35%
Date Price Change
24/24/24 1.26 -5.97%
23/24/23 1.34 +3.88%
22/24/22 1.29 +7.50%
21/24/21 1.2 +7.14%
20/24/20 1.12 -0.88%

Real-time BOERSE MUENCHEN

Last update May 25, 2024 at 01:15 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC6FJR
ISINDE000HC6FJR9
Date issued 03/05/2023
Strike 51.51
Maturity Unlimited
Parity 10 : 1
Emission price 1.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.17
Lowest since issue 0.35

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus